Home » Stocks » TWST

Twist Bioscience Corporation (TWST)

Stock Price: $104.30 USD -5.66 (-5.15%)
Updated May 6, 2021 4:00 PM EDT - Market closed
After-hours: $107.00 +2.70 (2.59%) May 6, 6:25 PM
Market Cap 5.35B
Revenue (ttm) 101.10M
Net Income (ttm) -117.19M
Shares Out 46.00M
EPS (ttm) -2.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $104.30
Previous Close $109.96
Change ($) -5.66
Change (%) -5.15%
Day's Open 106.79
Day's Range 101.64 - 108.88
Day's Volume 1,793,768
52-Week Range 34.16 - 214.07

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Twist Bioscience brings to mind another genomic revolution pioneer.

Other stocks mentioned: ARKG, ILMN
12 hours ago - The Motley Fool

Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

Investors will focus on the top-line and bottom-line numbers when Twist (TWST) reports fiscal second-quarter 2021 results.

1 week ago - Zacks Investment Research

SOUTH SAN FRANCISCO, Calif. & FRANKFURT--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using it...

1 week ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

2 weeks ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

2 weeks ago - Business Wire

And they all have one key thing in common.

Other stocks mentioned: REGN, VRTX, TDOC
2 weeks ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

3 weeks ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, toda...

3 weeks ago - Business Wire

SOUTH SAN FRANCISCO, Calif & BEIJING--(BUSINESS WIRE)--AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tumo...

4 weeks ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

4 weeks ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, is p...

1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif. & LA JOLLA, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA u...

1 month ago - Business Wire

These biotech companies are small, but they have tremendous growth prospects.

Other stocks mentioned: FATE
1 month ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif. & NEW YORK--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...

1 month ago - Business Wire

Sure, the ARK Invest CIO likes Tesla, but there are other stocks you might not know about.

Other stocks mentioned: TRMB
1 month ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon pl...

1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist began shipping its new synthetic RNA reference controls, including B.1.351 and P.1, that have emerged in South Africa and Brazil, respectively.

1 month ago - Business Wire

Twist Biosciences (TWST) is a biology company developing a breakthrough synthetic DNA technology that has the potential to change the world. The post A Golden Buying Opportunity Amid the Recent Tech Sec...

1 month ago - InvestorPlace

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

1 month ago - Business Wire

SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic ...

2 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

2 months ago - Business Wire

Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identifying methylated regions in the human geno...

2 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

2 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

2 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

2 months ago - Business Wire

Twist Bioscience Corp (NASDAQ: TWST) and Victorian Clinical Genetic Services (VCGS) have developed a novel whole-exome capture assay, which utilizes Next Generation Sequencing to conduct analysis and se...

2 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

2 months ago - Business Wire

An analyst downgraded the stock despite its better-than-expected quarterly results.

3 months ago - The Motley Fool

Twist Bioscience (TWST) delivered earnings and revenue surprises of 2.70% and 11.47%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Twist Bioscience (NASDAQ:TWST) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.00% over the past year to ($0.72), which...

3 months ago - Benzinga

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

3 months ago - Business Wire

Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...

3 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNADataStorage--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA us...

4 months ago - Business Wire

Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.

Other stocks mentioned: INO, MCRB, NVAX, PFE
4 months ago - The Motley Fool

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

4 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

These stocks look ripe for a 2021 breakout. Seeking Alpha Top Stocks makes it easy to find the strongest stocks in the market.

Other stocks mentioned: CELH, GRBK, TSM
5 months ago - Seeking Alpha

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

5 months ago - Business Wire

Twist Bioscience Corporation (TWST) CEO Emily Leprouston Q4 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Shares of Twist Bioscience (NASDAQ:TWST) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 43.75% year over year to ($0.54), which beat the estimate of...

5 months ago - Benzinga

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; and Kyowa Kiri... [Read more...]

Industry
Diagnostics & Research
IPO Date
Oct 31, 2018
CEO
Emily Leproust
Employees
525
Stock Exchange
NASDAQ
Ticker Symbol
TWST
Full Company Profile

Financial Performance

In 2020, TWST's revenue was $90.10 million, an increase of 65.67% compared to the previous year's $54.39 million. Losses were -$139.93 million, 30.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for TWST stock is "Buy." The 12-month stock price forecast is 146.00, which is an increase of 39.98% from the latest price.

Price Target
$146.00
(39.98% upside)
Analyst Consensus: Buy